Cargando…

BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma

Detalles Bibliográficos
Autores principales: Esteve-Arenys, Anna, Roue, Gael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978438/
https://www.ncbi.nlm.nih.gov/pubmed/29854869
http://dx.doi.org/10.18632/oncoscience.402
_version_ 1783327527604846592
author Esteve-Arenys, Anna
Roue, Gael
author_facet Esteve-Arenys, Anna
Roue, Gael
author_sort Esteve-Arenys, Anna
collection PubMed
description
format Online
Article
Text
id pubmed-5978438
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-59784382018-05-31 BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma Esteve-Arenys, Anna Roue, Gael Oncoscience Editorial Impact Journals LLC 2018-04-29 /pmc/articles/PMC5978438/ /pubmed/29854869 http://dx.doi.org/10.18632/oncoscience.402 Text en Copyright: © 2018 Esteve-Arenys and Roue http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Editorial
Esteve-Arenys, Anna
Roue, Gael
BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
title BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
title_full BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
title_fullStr BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
title_full_unstemmed BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
title_short BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
title_sort bfl-1 expression determines the efficacy of venetoclax in myc+/bcl2+ double hit lymphoma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978438/
https://www.ncbi.nlm.nih.gov/pubmed/29854869
http://dx.doi.org/10.18632/oncoscience.402
work_keys_str_mv AT estevearenysanna bfl1expressiondeterminestheefficacyofvenetoclaxinmycbcl2doublehitlymphoma
AT rouegael bfl1expressiondeterminestheefficacyofvenetoclaxinmycbcl2doublehitlymphoma